期刊文献+

依帕司他联合甲钴胺治疗高龄患者糖尿病周围神经病变 被引量:6

Effect of epalrestat combined with methylcobalamin on senior′s diabetic peripheral neuropathy
下载PDF
导出
摘要 目的观察依帕司他联合甲钴胺治疗高龄患者糖尿病周围神经病变的疗效。方法选取100例确诊为糖尿病周围神经病变的高龄患者随机分为2组,治疗组50例给予依帕司他及甲钴胺治疗,对照组50例给予甲钴胺治疗,疗程12周,观察两组患者的TCSS(Toronto临床评分系统)评分及双侧MCV和SCV变化。结果治疗后,两组患者TCSS评分及双侧腓总神经传导速度(MCV和SCV)显著改善(P<0.05),但治疗组较对照组改善更明显(P<0.05)。结论依帕司他联合甲钴胺治疗高龄患者糖尿病周围神经病变临床疗效理想,且优于单药治疗。 Objective To observe the curative effect of epalrestat combined with methylcobalamin on the senior's diabetic peripheral neuropathy (DPN). Methods 100 senior patients with diabetic peripheral neuropathy were randomly divided into two groups. Treatment group ( n = 50 ) received epalrestat combined with methylcobalamin. Control group ( n = 50 ) received only methylcobalamin. The changes of TCSS ( Toronto clinical scoring system) scores, motor and sensory nerve conduction velocity( MCV and SCV)of bilateral common peroneal nerve after 12 weeks were analyzed. Results After treatment, TCSS scores and conduction velocity (MCV and SCV)of bilateral common peroneal nerve of the 2 groups were obviously improved ( P 〈 0. 05 ) , and significant differences were observed between the 2 groups ( P 〈 0.05 ). Conclusion Epalrestat combined with methylcobalamin has ideal clinical curative effect on senior' s diabetic peripheral neuropathy, and it is superior to single drug treatment.
出处 《实用药物与临床》 CAS 2012年第9期543-545,共3页 Practical Pharmacy and Clinical Remedies
关键词 糖尿病周围神经病变 依帕司他 甲钴胺 Toronto临床评分系统(TCSS) 神经传导速度 Diabetic peripheral neuropathy Epalrestat Methylcobalamin Toronto clinical scoring system ( TCSS ) Nerve conduction velocity
  • 相关文献

参考文献9

二级参考文献64

共引文献162

同被引文献73

  • 1Yoshioka K,Okada H.Useful application of the neuropad test for assessment ofdiabetic polyneuropathy [J] .Intern Med,2012;51(23):3241 -3245. 被引量:1
  • 2Griebeler ML,Tsapas A,Brito JP,et al.Pharmacologic interventions for painfuldiabetic neuropalhytan umbrella systematic review and comparative effectivenessnetwork meta-analysis (Protocol)[J].Syst Rev}20I2;l( 1):61-63. 被引量:1
  • 3常乐军.灯盏细辛联合甲钴胺治疗糖尿病周围神经病变[J].中国实用神经疾病杂志,2007,10(9):120-122. 被引量:24
  • 4赵荣生,李晓光,翟所迪,张现化.用化学发光微粒子免疫法研究甲钴胺在人体内的药动学和生物等效性[J].中国药学杂志,2007,42(23):1809-1812. 被引量:4
  • 5Tesfaye S,Selvarajah D. Advances in the epidemiology,pathogenesis and management of diabetic peripheral neuropathy[J].Diabetes/Metabolism Research and Review,2012,(Suppl l):8-14. 被引量:1
  • 6Veves A,Backonja M,Malik RA. Painful diabetic neuropathy:epidemiology,natural history,early diagnosis,and treatment options[J].Pain Medicine,2008,(06):660-674. 被引量:1
  • 7Dyck PJ,Clark VM,Overland CJ. Impaired glycemia and diabetic polyneuropathy:the OC IG Survey[J].Diabetes Care,2012,(03):584-591. 被引量:1
  • 8Zhang W,Li S,Zheng X. Evaluation of the clinical efficacy of multiple lower extremity nerve decompression in diabetic peripheral neuropathy[J].J Neurol Surg A Cent Eur Neurosurg,2013,(02):96-100. 被引量:1
  • 9Ites KI,Anderson EJ,Cahill ML. Balance interventions for diabetic peripheral neuropathy:a systematic review[J].J Geriatr Phys Ther,2011,(03):109-116. 被引量:1
  • 10Sun Y,Lai MS,Lu CJ. Effectiveness of vitamin B12 on diabetic neuropathy: systematic review of clinical controlled trials[J].Acta Neurologica,2005,(02):48-54. 被引量:1

引证文献6

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部